Mira Mulvaney is an intellectual property litigation partner in the New York office of Kirkland & Ellis LLP. Her practice focuses on patent litigation in federal courts and the International Trade Commission. Mira has represented clients in the pharmaceutical, biotechnology, chemical and medical device industries. Mira has experience in all phases of litigation, including pre-suit analysis and strategy; discovery and depositions; claim construction; summary judgment; trial; post-trial; and appeal. She has also represented clients in USPTO inter partes review proceedings.

Mira also has experience counseling clients on patenting strategy, patenting evaluation, and IP due diligence relating to transactions, including licensing, joint ventures, and acquisitions.


Thought Leadership


Pat Carson and Mira Atanassova Mulvaney, CRISPR patents: guidance from US courts, in LIFE SCIENCES IP REVIEW (2018)

Pat Carson and Mira Mulvaney, Biomedical Patents: The Quest for Balance, in LIFE SCIENCES IP REVIEW (2016)

Dale Cendali and Mira Atanassova, Enforcement of Important Copyright Interests: a Practice Update, in IP ENFORCEMENT AND LITIGATION 2012: CIVIL AND CRIMINAL UPDATE 319 (Brian W. Brokate & Kathleen E. McCarthy eds., 2012)

Liu, J.; et al., Preparation of 3,4-fused-spiro[furan-5(5H),40-piperidin]-2-one, 40 Tetrahedron Lett. 5228 (2009)


Admissions & Qualifications

  • 2012, New York
  • Registered to practice before the United States Patent and Trademark Office


  • United States District Court for the Southern District of New York
  • United States District Court for the Eastern District of New York
  • United States Court of Appeals for the Federal Circuit


  • English
  • Bulgarian


  • Harvard Law SchoolJ.D.cum laude2011
    Line Editor, Harvard International Law Journal, 2009–2010
  • Barnard CollegeB.A., Chemistrysumma cum laude2008

    Dean’s List

    Phi Beta Kappa